+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Grand View Research
  • ID: 5734438
Description Jump to:

mRNA Synthesis Raw Materials Market Growth & Trends

The global mRNA synthesis raw materials market size is estimated to reach USD 2.30 billion by 2030, registering a CAGR of 5.78% from 2025 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.

The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.

Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.

Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.

Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.

However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.

mRNA Synthesis Raw Materials Market Report Highlights

  • By type, the capping agents segment is expected to grow with the fastest CAGR of 6.42% over the forecast period, owing to the advancements in the capping technology and their applications in the biopharma industry and research.
  • By application, the vaccine production segment dominated the global industry with the largest revenue share in 2024. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that utilize cell-culture-based production paths, which are often prone to failure.
  • North America dominated the global industry in 2024 and accounted for the largest share of more than 36.13% of the overall revenue in 2023, and is expected to grow at the highest CAGR over the forecast period.
  • By end-use, the biopharmaceutical and pharmaceutical companies segment dominated the market with the highest revenue share in 2023, due to the high commercial success of biopharmaceuticals and rapid growth in demand for therapeutics.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Application Segment
1.2.3. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Global mRNA Synthesis Raw Materials Market Variables & Trends
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. mRNA Synthesis Raw Materials Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Global mRNA Synthesis Raw Materials Market: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. Global mRNA Synthesis Raw Materials Market Type Movement Analysis
4.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Capping Agents
4.4.1. Capping agents market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. CleanCap Reagents (TriLink BioTechnology)
4.4.2.1. CleanCap reagents (TriLink BioTechnology) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. ARCA (Anti-Reverse Cap Analog)
4.4.3.1. ARCA (Anti-Reverse Cap Analog) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Nucleotides
4.5.1. Nucleotides market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Modified nucleic acids
4.5.2.1. Modified nucleic acids market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. N1-methylpseudouridine-triphosphate
4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.4. Others
4.5.2.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Natural nucleic acids
4.5.3.1. Natural nucleic acids market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.2. Adenine
4.5.3.2.1. Adenine-triphosphate market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.3. Guanine
4.5.3.3.1. Guanine market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.4. Cytosine
4.5.3.4.1. Cytosine market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.5. Uracil
4.5.3.5.1. Uracil market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Plasmid DNA
4.6.1. Plasmid DNA market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Enzymes
4.7.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
4.7.2. Polymerase
4.7.2.1. Polymerase market estimates and forecasts 2018 to 2030 (USD Million)
4.7.3. RNase Inhibitor
4.7.3.1. RNase inhibitor market estimates and forecasts 2018 to 2030 (USD Million)
4.7.4. DNase
4.7.4.1. DNase market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Global mRNA Synthesis Raw Materials Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Global mRNA Synthesis Raw Materials Market Application Movement Analysis
5.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Vaccine Production
5.4.1. Vaccine production market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Therapeutics Production
5.5.1. Therapeutics production market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Global mRNA Synthesis Raw Materials Market: End Use Estimates & Trend Analysis
6.1. End Use Segment Dashboard
6.2. Global mRNA Synthesis Raw Materials Market End Use Movement Analysis
6.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Biopharmaceutical & Pharmaceutical Companies
6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
6.5. CROs & CMOs
6.5.1. CROs & CMOs market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Academic & Research Institutes
6.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. MRNA Synthesis Raw Materials Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Denmark MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Australia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Thailand MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. South Korea MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. MEA MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. F. Hoffmann - La Roche Ltd.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Jena Bioscience Gmbh
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Merck KGaA
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Yeasen Biotechnology (Shanghai) Co.,Ltd.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. BOC Sciences
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Thermo Fisher Scientific, Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Maravai Lifesciences
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. New England Biolabs
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Creative Biogene
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Hongene
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 5 Global mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 6 Global mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 7 Global mRNA synthesis raw materials Market, By Region, 2018 - 2030 (USD Million)
Table 8 North America mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 10 North America mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 11 North America mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 12 U.S. mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 13 U.S. mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 14 U.S. mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 15 Canada mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 16 Canada mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 17 Canada mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 18 Mexico mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 19 Mexico mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 20 Mexico mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 21 Europe mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
Table 22 Europe mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 23 Europe mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 24 Europe mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 25 UK mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 26 UK mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 27 UK mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
Table 28 Germany mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 29 Germany mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 30 Germany mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 31 France mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 32 France mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 33 France mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 34 Spain mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 35 Spain mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 36 Spain mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 37 Italy mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 38 Italy mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 39 Italy mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 40 Denmark mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 41 Denmark mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 42 Denmark mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 43 Norway mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 44 Norway mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 45 Norway mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 46 Sweden mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 47 Sweden mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 48 Sweden mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 49 Asia Pacific mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
Table 50 Asia Pacific mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 51 Asia Pacific mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 52 Asia Pacific mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 53 China mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 54 China mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 55 China mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 56 Japan mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 57 Japan mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 58 Japan mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 59 India mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 60 India mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 61 India mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 62 South Korea mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 63 South Korea mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 64 South Korea mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 65 Australia mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 66 Australia mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 67 Australia mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 68 Thailand mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 69 Thailand mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 70 Thailand mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 71 Latin America mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
Table 72 Latin America mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 73 Latin America mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 74 Latin America mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
Table 75 Brazil mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 76 Brazil mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 77 Brazil mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 78 Argentina mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million),
Table 79 Argentina mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 80 Argentina mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 81 MEA mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
Table 82 MEA mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 83 MEA mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 84 MEA mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
Table 85 South Africa mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 86 South Africa mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 87 South Africa mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 88 UAE mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 89 UAE mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 90 UAE mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million),
Table 92 Saudi Arabia mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 93 Saudi Arabia mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
Table 94 Kuwait mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
Table 95 Kuwait mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
Table 96 Kuwait mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 mRNA synthesis raw materials market segmentation
Fig. 2 Information procurement
Fig. 3 Data analysis models
Fig. 4 Market formulation and validation
Fig. 5 Data validating & publishing
Fig. 6 Market research process
Fig. 7 Information procurement
Fig. 8 Primary research
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 mRNA synthesis raw materials market: Type outlook key takeaways
Fig. 13 mRNA synthesis raw materials market: Type movement analysis
Fig. 14 Global capping agents market, 2018 - 2030 (USD Million)
Fig. 15 Global cleancap reagents market, 2018 - 2030 (USD Million)
Fig. 16 Global ARCA (anti-reverse cap analog) market, 2018 - 2030 (USD Million)
Fig. 17 Global others market, 2018 - 2030 (USD Million)
Fig. 18 Global nucleotides market, 2018 - 2030 (USD Million)
Fig. 19 Global modified nucleic acid market, 2018 - 2030 (USD Million)
Fig. 20 Global N1-methylpseudouridine-triphosphate market, 2018 - 2030 (USD Million)
Fig. 21 Global 5-Methylcytidine triphosphate (5mCTP) market, 2018 - 2030 (USD Million)
Fig. 22 Global others market, 2018 - 2030 (USD Million)
Fig. 23 Global natural nucleic acids market, 2018 - 2030 (USD Million)
Fig. 24 Global adenine market, 2018 - 2030 (USD Million)
Fig. 25 Global guanine market, 2018 - 2030 (USD Million)
Fig. 26 Global cytosine market, 2018 - 2030 (USD Million)
Fig. 27 Global uracil market, 2018 - 2030 (USD Million)
Fig. 28 Global plasmid DNA market, 2018 - 2030 (USD Million)
Fig. 29 Global enzymes mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
Fig. 30 Global polymerase market, 2018 - 2030 (USD Million)
Fig. 31 Global RNase inhibitor market, 2018 - 2030 (USD Million)
Fig. 32 Global DNase market, 2018 - 2030 (USD Million)
Fig. 33 Global others market, 2018 - 2030 (USD Million)
Fig. 34 Global others mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
Fig. 35 mRNA synthesis raw materials market: Application outlook and key takeaways
Fig. 36 mRNA synthesis raw materials market: Application movement analysis
Fig. 37 Global therapeutics production market, 2018 - 2030 (USD Million)
Fig. 38 Global vaccine production market, 2018 - 2030 (USD Million)
Fig. 39 Global other applications market, 2018 - 2030 (USD Million)
Fig. 40 mRNA synthesis raw materials market: End-user outlook and key takeaways
Fig. 41 mRNA synthesis raw materials market: End-user movement analysis
Fig. 42 Global biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 43 Global CROs & CMOs market, 2018 - 2030 (USD Million)
Fig. 44 Global academic & research institutes market, 2018 - 2030 (USD Million)
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 North America mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 U.S. mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Canada mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Mexico mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Europe mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Germany mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 UK mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 France mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Italy mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Spain mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Market scenario
Fig. 66 Key country dynamics
Fig. 67 Denmark mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Regulatory framework
Fig. 69 Key country dynamics
Fig. 70 Norway mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Regulatory framework
Fig. 72 Key country dynamics
Fig. 73 Sweden mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Regulatory framework
Fig. 75 Asia Pacific mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Japan mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 China mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 India mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Australia mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Thailand mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 South Korea mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Latin America mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Brazil mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Argentina mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 MEA mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 South Africa mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Saudi Arabia mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 UAE mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Kuwait mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Jena Bioscience GmbH
  • Merck KGaA
  • Yeasen Biotechnology (Shanghai) Co., Ltd.
  • BOC Sciences
  • Thermo Fisher Scientific, Inc.
  • Maravai LifeSciences
  • New England Biolabs
  • Creative Biogene
  • HONGENE.

Table Information

Report AttributeDetails
No. of Pages150
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.67 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.3 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

mRNA Synthesis & Manufacturing Market by Services, Service Type, Manufacturing Process, Manufacturing Scale, Technology, Application, Usage, End-User - Global Forecast to 2030 - Product Image

mRNA Synthesis & Manufacturing Market by Services, Service Type, Manufacturing Process, Manufacturing Scale, Technology, Application, Usage, End-User - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
mRNA Synthesis Raw Materials - Global Strategic Business Report - Product Image

mRNA Synthesis Raw Materials - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Messenger Ribonucleic Acid (MRNA) Synthesis Raw Materials Market Report 2025 - Product Image

Messenger Ribonucleic Acid (MRNA) Synthesis Raw Materials Market Report 2025

  • Report
  • 200 Pages
  • Global
From
mRNA Therapeutics Market by Technology Platform, Therapeutic Application, Delivery Method - Global Forecast to 2030 - Product Image

mRNA Therapeutics Market by Technology Platform, Therapeutic Application, Delivery Method - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
MRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-Up), Application (CGT, Vaccines) - Global Forecast to 2029 - Product Image

MRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-Up), Application (CGT, Vaccines) - Global Forecast to 2029

  • Report
  • 351 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.